Brian Levy
Pharmaceuticals - San Diego, California, United States
Brian Levy Employees
Brian Levy Details
Clinical stage company developing an orally administered compound to inhibit the dysregulated NLRP3 Inflammasome pathway of autoinflammation. Indications: Diabetic Macular Edema (DME) secondary to Diabetic Retinopathy (DR) and Chronic Kidney Disease secondary to Diabetic Nephropathy (DN)
Website:
http://www.inflammx.com
Employees:
6
HQ:
+1 858-677-0474
Location:
San Diego, California, United States
Revenue:
5M
Brian Levy Technologies
Email Providers
Outlook
Domain Name Services
EasyDNS
Fonts
Typekit
Other
Mobile Friendly